ANI Pharmaceuticals
ANIP
$65.27
Share price
-0.14%
Change (1 day)
73.04%
Change (1 year)
Categories
EPS for ANI Pharmaceuticals (ANIP)
EPS in 2023 (TTM): -$0.47
According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.47. In 2022 the company made an earnings per share (EPS) of -$3.04 an increase over its 2021 EPS that were of -$3.25.
EPS history for ANI Pharmaceuticals from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.47 | -84.54% |
| 2022 | -$3.04 | -6.46% |
| 2021 | -$3.25 | 72.87% |
| 2020 | -$1.88 | -476% |
| 2019 | $0.50 | -62.12% |
| 2018 | $1.32 | -1566.67% |
| 2017 | -$0.09000 | -126.47% |
| 2016 | $0.34 | -74.63% |
| 2015 | $1.34 | -47.66% |
| 2014 | $2.56 | -142.11% |
| 2013 | -$6.08 | -21.45% |
| 2012 | -$7.74 | -59.43% |
| 2011 | -$19.08 | -25.53% |
| 2010 | -$25.62 | -49.17% |
| 2009 | -$50.40 | 122.22% |
| 2008 | -$22.68 | 110% |
| 2007 | -$10.80 | -350% |
| 2006 | $4.32 | -124% |
| 2005 | -$18.00 | -28.57% |
| 2004 | -$25.20 | 27.27% |
| 2003 | -$19.80 | 0% |
| 2002 | -$19.80 | 27.91% |
| 2001 | -$15.48 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $3.74 | -895.74% | 🇨🇭 Switzerland |
 Pfizer PFE | $1.86 | -495.74% | 🇺🇸 USA |
 Cardinal Health CAH | $1.01 | -314.89% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | -$1.41 | 200.00% | 🇮🇪 Ireland |
 Evoke Pharma
EVOK | -$2.36 | 402.13% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -$2.40 | 410.64% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -$2.00 | 325.53% | 🇮🇱 Israel |
 Royalty Pharma RPRX | $0.55 | -217.02% | 🇬🇧 UK |
 Lannett Company LCI | -$25.28 | 5,278.72% | 🇺🇸 USA |